|
SERF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.177000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.000800E-01 |
| Normal-vs-Stage2 |
9.066600E-01 |
| Normal-vs-Stage3 |
9.811600E-01 |
| Normal-vs-Stage4 |
6.652800E-01 |
| Stage1-vs-Stage2 |
5.882000E-01 |
| Stage1-vs-Stage3 |
5.301200E-01 |
| Stage1-vs-Stage4 |
9.808400E-01 |
| Stage2-vs-Stage3 |
8.776800E-01 |
| Stage2-vs-Stage4 |
6.408400E-01 |
| Stage3-vs-Stage4 |
6.735600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.208400E-01 |
| Normal-vs-AfricanAmerican |
5.152600E-01 |
| Normal-vs-Asian |
6.011400E-01 |
| Caucasian-vs-AfricanAmerican |
6.958400E-01 |
| Caucasian-vs-Asian |
8.053400E-01 |
| AfricanAmerican-vs-Asian |
8.332200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.073200E-01 |
| Normal-vs-Female |
5.632200E-01 |
| Male-vs-Female |
2.402000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.233800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.322200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.091600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.318200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.533600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.775200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.643600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.471600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.001000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.008400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.486400E-01 |
| Classical-VS-Follicular |
8.683500E-03 |
| Classical-VS-Other |
1.108760E-01 |
| Classical-VS-Normal |
2.700800E-01 |
| Tall-VS-Follicular |
1.313150E-01 |
| Tall-VS-Other |
1.584790E-01 |
| Tall-VS-Normal |
4.800000E-01 |
| Follicular-VS-Other |
6.594200E-01 |
| Follicular-VS-Normal |
2.569400E-01 |
| Other-VS-Normal |
2.796600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.716000E-01 |
| Normal-vs-N1 |
3.706000E-01 |
| N0-vs-N1 |
2.984400E-01 |
|
|
